Your browser doesn't support javascript.
loading
Breast Cancer Index and prediction of benefit from extended endocrine therapy in breast cancer patients treated in the Adjuvant Tamoxifen-To Offer More? (aTTom) trial.
Bartlett, J M S; Sgroi, D C; Treuner, K; Zhang, Y; Ahmed, I; Piper, T; Salunga, R; Brachtel, E F; Pirrie, S J; Schnabel, C A; Rea, D W.
Afiliação
  • Bartlett JMS; Ontario Institute for Cancer Research, Toronto, Canada; University of Edinburgh Cancer Research Centre, Edinburgh, UK. Electronic address: john.bartlett@oicr.on.ca.
  • Sgroi DC; Department of Pathology, Massachusetts General Hospital, Boston, MA.
  • Treuner K; Biotheranostics Inc., San Diego, USA.
  • Zhang Y; Biotheranostics Inc., San Diego, USA.
  • Ahmed I; Cancer Research UK Clinical Trials Unit (CRCTU), Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
  • Piper T; University of Edinburgh Cancer Research Centre, Edinburgh, UK.
  • Salunga R; Biotheranostics Inc., San Diego, USA.
  • Brachtel EF; Department of Pathology, Massachusetts General Hospital, Boston, MA.
  • Pirrie SJ; Cancer Research UK Clinical Trials Unit (CRCTU), Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
  • Schnabel CA; Biotheranostics Inc., San Diego, USA.
  • Rea DW; Cancer Research UK Clinical Trials Unit (CRCTU), Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
Ann Oncol ; 30(11): 1776-1783, 2019 11 01.
Article em En | MEDLINE | ID: mdl-31504126
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tamoxifeno / Neoplasias da Mama / Biomarcadores Tumorais / Antineoplásicos Hormonais / Recidiva Local de Neoplasia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tamoxifeno / Neoplasias da Mama / Biomarcadores Tumorais / Antineoplásicos Hormonais / Recidiva Local de Neoplasia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article